Equine IgG (HiGamm-Equi)
For intravenous use in treatment of Failure of Passive Transfer in the equine neonate at the rate of 20 ml/kg. body weight. The diagnosis of Failure of Passive Transfer should be established from a blood sample taken at least 18 hours after birth.
Each single bag contains:
- Plasma, as a source of equine IgG with sodium citrate as an anticoagulant derived from healthy horses with Aa and Ca r.b.c. antigens and no r.b.c. antibodies
- All donor horses are negative for EIA, EVA, Dourine, Brucellosis, Piroplasmosis, Glanders and Equine Parvovirus-Hepatitis
- There is no preservative added